BackRareX Limited Overview

RareX Limited EBIT

RareX Limited's EBIT is $-10M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.44M
↓ 37.98% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$10.48M
↑ 32.7% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

RareX Limited (REEEF) FAQ

The latest EBIT for REEEF is $-10M as of June 2026. That compares with $-16M in the prior-year period — up 32.7% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside RareX Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, REEEF's EBIT moved from $-16M to $-10M — a 32.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RareX Limited's operating scale or balance-sheet position.

Against its sector companies, REEEF currently prints $-10M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at RareX Limited's growth, margins, and balance sheet.

A EBIT figure of $-10M for REEEF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting REEEF's EBIT ($-10M), review year-over-year change from $-16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.